13F

VXRT VAXART INC

2026Q1 · CUSIP 92243A200 · Sector: Healthcare & Biotech

Neutral · No signal
Holders
5
Δ holders QoQ
0
Breadth percentile
n/a
Whale holders
1
Δ whales
+1
Inst. holding value
$34K
New positions
2
Closed positions
2
Price momentum (1Q)
Put / Call
0/0

Breadth history (34 quarters)

2018Q2: Δ-1 · h=18 2018Q3: Δ+5 · h=23 2018Q4: Δ-1 · h=22 2019Q1: Δ-4 · h=18 2019Q2: Δ+3 · h=21 2019Q3: Δ+1 · h=22 2019Q4: Δ+0 · h=22 2020Q1: Δ+19 · h=41 2020Q2: Δ+47 · h=88 2020Q3: Δ+37 · h=125 2020Q4: Δ+13 · h=138 2021Q1: Δ+19 · h=157 2021Q2: Δ-12 · h=145 2021Q3: Δ-4 · h=141 2021Q4: Δ+6 · h=147 2022Q1: Δ+1 · h=148 2022Q2: Δ-3 · h=145 2022Q3: Δ-2 · h=143 2022Q4: Δ-10 · h=133 2023Q1: Δ-24 · h=109 2023Q2: Δ+2 · h=111 2023Q3: Δ-14 · h=97 2023Q4: Δ-9 · h=88 2024Q1: Δ+16 · h=104 2024Q2: Δ-5 · h=99 2024Q3: Δ+3 · h=102 2024Q4: Δ-8 · h=94 2025Q1: Δ+0 · h=94 2025Q2: Δ+5 · h=99 2025Q3: Δ-82 · h=17 2025Q4: Δ-12 · h=5 2026Q1: Δ+0 · h=5 2018Q2: holders=18 2018Q3: holders=23 2018Q4: holders=22 2019Q1: holders=18 2019Q2: holders=21 2019Q3: holders=22 2019Q4: holders=22 2020Q1: holders=41 2020Q2: holders=88 2020Q3: holders=125 2020Q4: holders=138 2021Q1: holders=157 2021Q2: holders=145 2021Q3: holders=141 2021Q4: holders=147 2022Q1: holders=148 2022Q2: holders=145 2022Q3: holders=143 2022Q4: holders=133 2023Q1: holders=109 2023Q2: holders=111 2023Q3: holders=97 2023Q4: holders=88 2024Q1: holders=104 2024Q2: holders=99 2024Q3: holders=102 2024Q4: holders=94 2025Q1: holders=94 2025Q2: holders=99 2025Q3: holders=17 2025Q4: holders=5 2026Q1: holders=5 -82 -41 +0 +41 +82 485165 18Q219Q220Q221Q222Q223Q224Q225Q226Q1 Δ holders (bar) Holders (line)

Past Lit Events & Aftermath 5 lit events

Period Percentile Next-1Q return Next-2Q return
2024Q1 Top 19%
2021Q1 Top 19% +31.3% +5.9%
2020Q3 Top 5% +30.9% +18.1%
2020Q2 Top 6% -50.1% -21.9%
2020Q1 Top 4%

Options Sentiment

Put holders
0
QoQ: 0
Call holders
0
QoQ: 0

See methodology →

Fundamentals

PE (TTM)
3.5
EPS (TTM)
$0.16
EPS YoY
Revenue (TTM)
$0.3B
Revenue YoY
+439.3%
Quarterly Revenue & EPS (4Y)
2023-03-31: $1M 2023-06-30: $1M 2023-09-30: $2M 2023-12-31: $3M 2024-03-31: $2M 2024-06-30: $6M 2024-09-30: $5M 2024-12-31: $15M 2025-03-31: $21M 2025-06-30: $40M 2025-09-30: $72M 2025-12-31: $104M 2026-03-31: $39M 2022-06-30: EPS -0.23 2022-09-30: EPS -0.23 2022-12-31: EPS -0.18 2023-03-31: EPS -0.19 2023-06-30: EPS -0.16 2023-09-30: EPS -0.11 2023-12-31: EPS -0.11 2024-03-31: EPS -0.14 2024-06-30: EPS -0.09 2024-09-30: EPS -0.06 2024-12-31: EPS -0.04 2025-03-31: EPS -0.07 2025-06-30: EPS -0.07 2025-09-30: EPS -0.04 2025-12-31: EPS 0.25 2026-03-31: EPS 0.02 0M 52M 104M $M -0.25 0.01 0.28 20222023202420252026 Revenue EPS

Quarterly figures; EPS split-adjusted, early quarters hidden when not calibrable

P/E (TTM) over time
4Y median 8 2025-12-31: PE 8.12026-03-31: PE 4.3 4 6 9 20222023202420252026

P/E = close 47 days after quarter-end (filing date) ÷ TTM EPS then; loss quarters hidden

As of 2026-03-31 · SEC filings (XBRL)